At a time when the Japanese government had not yet established the handling classification (food or drug?), we focused on the usefulness of NMN in animal studies in Japan and overseas, and conducted our own research on human safety and usefulness for about three years.

Then, in order to commercialize NMN in a manner compliant with the law, we lobbied the Ministry of Health, Labor and Welfare to amend the law to make NMN a "non-medical product" by submitting various safety data obtained through our research.

As a result, NMN was recognized as a non-medical product ahead of the rest of the world, and INFINIXX began marketing NMN Sirtuin®, the first NMN product to comply with the law.

These commitments to safety, quality, and integrity for our customers have remained constant from the beginning 290 years ago to the present, and will remain unchanged as time goes on.

Tomotaka Abe, 10th generation president of the company